Simone V. D. S.
- Country
- The Netherlands
- Department
- Respiratory Deparment
Research Overview
- Efficacy and Safety of Early Depemokimab Initiation as Add-on Therapy in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
- Phase 2a Randomized, Double‑Blind, Placebo‑Controlled Study of Subcutaneous SAR445399 on Mucus Plug Score in Adults with Non‑Cystic Fibrosis Bronchiectasis
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Study Evaluating Efficacy and Safety of Lunsekimig in Adults with Inadequately Controlled Eosinophilic COPD
Data & Insights
Has run more than one trial at 213 of 555 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating chronic obstructive pulmonary disease (COPD), focusing on evaluating novel therapeutic approaches for moderate to severe cases. Their research encompasses long-term management strategies and exacerbation prevention in former smokers.
- COPD Exacerbation Management
- Long-term Disease Control
- Therapeutic Safety Assessment
Asthma Treatment Innovation
The investigator has extensive experience in severe asthma management, particularly focusing on patients with eosinophilic phenotypes. Their work includes evaluation of new delivery systems and therapeutic options for moderate to severe uncontrolled asthma.
- Eosinophilic Asthma Treatment
- Inhaler Technology Assessment
- Therapeutic Response Monitoring
Specialized Respiratory Conditions
Their expertise extends to treating complex respiratory conditions including non-cystic fibrosis bronchiectasis and refractory chronic cough. The investigator also studies respiratory syncytial virus infections and innovative vaccination approaches.
- Bronchiectasis Management
- Chronic Cough Treatment
- Respiratory Immunology
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.